Search research articles
Contact Us
Filters
Showing results (121-130 of 156) with videos related to
Page
of 16
Sort By:
Emerging Infectious Diseases
|
June 23, 2004
Multistate shigellosis outbreak and commercially prepared food, United States
Akiko C Kimura, Kammy Johnson, Mary S Palumbo, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 9, 2024
Hepatocyte-independent PAR1-biased signaling controls liver pathology in experimental obesity
Holly Cline, Zimu Wei, Dafna J Groeneveld, et al.
Journal of Thrombosis and Haemostasis : JTH
|
March 5, 2008
Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell function
J S Palumbo, K A Barney, E A Blevins, et al.
Transplantation Proceedings
|
May 2, 2017
Electrospun Polyhydroxyethyl-Aspartamide-Polylactic Acid Scaffold for Biliary Duct Repair: A Preliminary In Vivo Evaluation
S Buscemi, G Damiano, S Fazzotta, et al.
Allergy
|
August 30, 2023
The key roles of thrombin and fibrinogen in human infant and mice atopic dermatitis models
Alyssa L Filuta, Peter Amezcua, Brandy P Ruff, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 14, 2021
Host fibrinogen drives antimicrobial function in <i>Staphylococcus aureus</i> peritonitis through bacterial-mediated prothrombin activation
Joni M Prasad, Oscar Negrón, Xinli Du, et al.
Scientific Reports
|
July 13, 2021
Cell type-specific roles of PAR1 in Coxsackievirus B3 infection
Michael F Bode, Clare M Schmedes, Grant J Egnatz, et al.
Nature Communications
|
April 6, 2023
MEK inhibition reduced vascular tumor growth and coagulopathy in a mouse model with hyperactive GNAQ
Sandra Schrenk, Lindsay J Bischoff, Jillian Goines, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 20, 2006
Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas
Brigitte C Widemann, Wanda L Salzer, Robert J Arceci, et al.
Cancer Research
|
April 9, 2014
Thrombin drives tumorigenesis in colitis-associated colon cancer
Brian Turpin, Whitney Miller, Leah Rosenfeldt, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 156) with videos related to
Sort By:
Page
of 16
Emerging Infectious Diseases
|
June 23, 2004
Multistate shigellosis outbreak and commercially prepared food, United States
Akiko C Kimura, Kammy Johnson, Mary S Palumbo, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 9, 2024
Hepatocyte-independent PAR1-biased signaling controls liver pathology in experimental obesity
Holly Cline, Zimu Wei, Dafna J Groeneveld, et al.
Journal of Thrombosis and Haemostasis : JTH
|
March 5, 2008
Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell function
J S Palumbo, K A Barney, E A Blevins, et al.
Transplantation Proceedings
|
May 2, 2017
Electrospun Polyhydroxyethyl-Aspartamide-Polylactic Acid Scaffold for Biliary Duct Repair: A Preliminary In Vivo Evaluation
S Buscemi, G Damiano, S Fazzotta, et al.
Allergy
|
August 30, 2023
The key roles of thrombin and fibrinogen in human infant and mice atopic dermatitis models
Alyssa L Filuta, Peter Amezcua, Brandy P Ruff, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 14, 2021
Host fibrinogen drives antimicrobial function in <i>Staphylococcus aureus</i> peritonitis through bacterial-mediated prothrombin activation
Joni M Prasad, Oscar Negrón, Xinli Du, et al.
Scientific Reports
|
July 13, 2021
Cell type-specific roles of PAR1 in Coxsackievirus B3 infection
Michael F Bode, Clare M Schmedes, Grant J Egnatz, et al.
Nature Communications
|
April 6, 2023
MEK inhibition reduced vascular tumor growth and coagulopathy in a mouse model with hyperactive GNAQ
Sandra Schrenk, Lindsay J Bischoff, Jillian Goines, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 20, 2006
Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas
Brigitte C Widemann, Wanda L Salzer, Robert J Arceci, et al.
Cancer Research
|
April 9, 2014
Thrombin drives tumorigenesis in colitis-associated colon cancer
Brian Turpin, Whitney Miller, Leah Rosenfeldt, et al.
Page
of 16